nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—SLC22A8—choroid plexus—malignant glioma	0.161	0.298	CbGeAlD
Ceftriaxone—SLC15A2—choroid plexus—malignant glioma	0.14	0.259	CbGeAlD
Ceftriaxone—GLUL—embryo—malignant glioma	0.0234	0.0433	CbGeAlD
Ceftriaxone—GLUL—brainstem—malignant glioma	0.0214	0.0397	CbGeAlD
Ceftriaxone—GLUL—retina—malignant glioma	0.0207	0.0383	CbGeAlD
Ceftriaxone—Lymphopenia—Temozolomide—malignant glioma	0.0206	0.0447	CcSEcCtD
Ceftriaxone—GLUL—telencephalon—malignant glioma	0.019	0.0352	CbGeAlD
Ceftriaxone—Nephropathy toxic—Carmustine—malignant glioma	0.019	0.0412	CcSEcCtD
Ceftriaxone—GLUL—medulla oblongata—malignant glioma	0.0149	0.0277	CbGeAlD
Ceftriaxone—Cholestasis—Temozolomide—malignant glioma	0.0139	0.0301	CcSEcCtD
Ceftriaxone—GLUL—midbrain—malignant glioma	0.0137	0.0253	CbGeAlD
Ceftriaxone—Coagulopathy—Temozolomide—malignant glioma	0.0135	0.0294	CcSEcCtD
Ceftriaxone—GLUL—spinal cord—malignant glioma	0.0133	0.0247	CbGeAlD
Ceftriaxone—Drug interaction—Carmustine—malignant glioma	0.0118	0.0255	CcSEcCtD
Ceftriaxone—Leukocytosis—Carmustine—malignant glioma	0.0116	0.0252	CcSEcCtD
Ceftriaxone—GLUL—central nervous system—malignant glioma	0.0108	0.02	CbGeAlD
Ceftriaxone—SLC15A2—retina—malignant glioma	0.0107	0.0198	CbGeAlD
Ceftriaxone—GLUL—cerebellum—malignant glioma	0.0106	0.0196	CbGeAlD
Ceftriaxone—Vaginal inflammation—Temozolomide—malignant glioma	0.0105	0.0229	CcSEcCtD
Ceftriaxone—Candida infection—Carmustine—malignant glioma	0.0104	0.0226	CcSEcCtD
Ceftriaxone—Candida infection—Temozolomide—malignant glioma	0.0101	0.0219	CcSEcCtD
Ceftriaxone—Vaginal infection—Temozolomide—malignant glioma	0.00995	0.0216	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Temozolomide—malignant glioma	0.00989	0.0215	CcSEcCtD
Ceftriaxone—SLC15A2—telencephalon—malignant glioma	0.00982	0.0182	CbGeAlD
Ceftriaxone—Phlebitis—Carmustine—malignant glioma	0.00919	0.02	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Carmustine—malignant glioma	0.00914	0.0199	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Temozolomide—malignant glioma	0.00884	0.0192	CcSEcCtD
Ceftriaxone—GLUL—brain—malignant glioma	0.00858	0.0159	CbGeAlD
Ceftriaxone—SLC22A6—brain—malignant glioma	0.00852	0.0158	CbGeAlD
Ceftriaxone—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00811	0.0176	CcSEcCtD
Ceftriaxone—SLC15A2—medulla oblongata—malignant glioma	0.00772	0.0143	CbGeAlD
Ceftriaxone—Ataxia—Carmustine—malignant glioma	0.00744	0.0162	CcSEcCtD
Ceftriaxone—Ataxia—Temozolomide—malignant glioma	0.00719	0.0156	CcSEcCtD
Ceftriaxone—SLC15A2—midbrain—malignant glioma	0.00706	0.0131	CbGeAlD
Ceftriaxone—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00689	0.015	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00689	0.015	CcSEcCtD
Ceftriaxone—SLC15A2—spinal cord—malignant glioma	0.00688	0.0128	CbGeAlD
Ceftriaxone—Sweating increased—Temozolomide—malignant glioma	0.00644	0.014	CcSEcCtD
Ceftriaxone—SLC22A8—central nervous system—malignant glioma	0.00643	0.0119	CbGeAlD
Ceftriaxone—Neutropenia—Carmustine—malignant glioma	0.0064	0.0139	CcSEcCtD
Ceftriaxone—Neutropenia—Temozolomide—malignant glioma	0.00618	0.0134	CcSEcCtD
Ceftriaxone—Renal failure—Carmustine—malignant glioma	0.006	0.013	CcSEcCtD
Ceftriaxone—Stomatitis—Carmustine—malignant glioma	0.00595	0.0129	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00584	0.0127	CcSEcCtD
Ceftriaxone—Stomatitis—Temozolomide—malignant glioma	0.00575	0.0125	CcSEcCtD
Ceftriaxone—SLC15A2—central nervous system—malignant glioma	0.00558	0.0103	CbGeAlD
Ceftriaxone—Haemoglobin—Carmustine—malignant glioma	0.0055	0.012	CcSEcCtD
Ceftriaxone—Haemorrhage—Carmustine—malignant glioma	0.00548	0.0119	CcSEcCtD
Ceftriaxone—SLC15A2—cerebellum—malignant glioma	0.00546	0.0101	CbGeAlD
Ceftriaxone—Haemoglobin—Temozolomide—malignant glioma	0.00532	0.0116	CcSEcCtD
Ceftriaxone—ALB—brain—malignant glioma	0.00531	0.00984	CbGeAlD
Ceftriaxone—Haemorrhage—Temozolomide—malignant glioma	0.00529	0.0115	CcSEcCtD
Ceftriaxone—SLC22A8—brain—malignant glioma	0.0051	0.00945	CbGeAlD
Ceftriaxone—Flushing—Carmustine—malignant glioma	0.00508	0.011	CcSEcCtD
Ceftriaxone—Erythema multiforme—Temozolomide—malignant glioma	0.005	0.0109	CcSEcCtD
Ceftriaxone—Flushing—Temozolomide—malignant glioma	0.00491	0.0107	CcSEcCtD
Ceftriaxone—Chills—Temozolomide—malignant glioma	0.00475	0.0103	CcSEcCtD
Ceftriaxone—Dysgeusia—Temozolomide—malignant glioma	0.00451	0.0098	CcSEcCtD
Ceftriaxone—SLC15A2—brain—malignant glioma	0.00443	0.00822	CbGeAlD
Ceftriaxone—Anaemia—Carmustine—malignant glioma	0.00441	0.00957	CcSEcCtD
Ceftriaxone—Agitation—Carmustine—malignant glioma	0.00438	0.00951	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Temozolomide—malignant glioma	0.00427	0.00928	CcSEcCtD
Ceftriaxone—Leukopenia—Carmustine—malignant glioma	0.00427	0.00927	CcSEcCtD
Ceftriaxone—Anaemia—Temozolomide—malignant glioma	0.00426	0.00925	CcSEcCtD
Ceftriaxone—Agitation—Temozolomide—malignant glioma	0.00423	0.00919	CcSEcCtD
Ceftriaxone—Malaise—Temozolomide—malignant glioma	0.00415	0.00902	CcSEcCtD
Ceftriaxone—Convulsion—Carmustine—malignant glioma	0.00413	0.00897	CcSEcCtD
Ceftriaxone—Leukopenia—Temozolomide—malignant glioma	0.00412	0.00896	CcSEcCtD
Ceftriaxone—Palpitations—Temozolomide—malignant glioma	0.00407	0.00884	CcSEcCtD
Ceftriaxone—Convulsion—Temozolomide—malignant glioma	0.00399	0.00867	CcSEcCtD
Ceftriaxone—Oedema—Carmustine—malignant glioma	0.00389	0.00845	CcSEcCtD
Ceftriaxone—Discomfort—Temozolomide—malignant glioma	0.00387	0.00842	CcSEcCtD
Ceftriaxone—Infection—Carmustine—malignant glioma	0.00386	0.00839	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Carmustine—malignant glioma	0.00381	0.00827	CcSEcCtD
Ceftriaxone—Oedema—Temozolomide—malignant glioma	0.00376	0.00817	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Temozolomide—malignant glioma	0.00376	0.00817	CcSEcCtD
Ceftriaxone—Infection—Temozolomide—malignant glioma	0.00373	0.00811	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Temozolomide—malignant glioma	0.00368	0.008	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Temozolomide—malignant glioma	0.00363	0.00789	CcSEcCtD
Ceftriaxone—Paraesthesia—Carmustine—malignant glioma	0.00349	0.00759	CcSEcCtD
Ceftriaxone—Paraesthesia—Temozolomide—malignant glioma	0.00338	0.00733	CcSEcCtD
Ceftriaxone—Pain—Carmustine—malignant glioma	0.00333	0.00723	CcSEcCtD
Ceftriaxone—Dyspepsia—Temozolomide—malignant glioma	0.00331	0.00719	CcSEcCtD
Ceftriaxone—Pain—Temozolomide—malignant glioma	0.00321	0.00698	CcSEcCtD
Ceftriaxone—Feeling abnormal—Carmustine—malignant glioma	0.00321	0.00696	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Carmustine—malignant glioma	0.00318	0.00691	CcSEcCtD
Ceftriaxone—Feeling abnormal—Temozolomide—malignant glioma	0.0031	0.00673	CcSEcCtD
Ceftriaxone—Abdominal pain—Carmustine—malignant glioma	0.00308	0.00668	CcSEcCtD
Ceftriaxone—Body temperature increased—Carmustine—malignant glioma	0.00308	0.00668	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Temozolomide—malignant glioma	0.00307	0.00668	CcSEcCtD
Ceftriaxone—Urticaria—Temozolomide—malignant glioma	0.00299	0.00649	CcSEcCtD
Ceftriaxone—Abdominal pain—Temozolomide—malignant glioma	0.00297	0.00646	CcSEcCtD
Ceftriaxone—Body temperature increased—Temozolomide—malignant glioma	0.00297	0.00646	CcSEcCtD
Ceftriaxone—Hypersensitivity—Carmustine—malignant glioma	0.00287	0.00623	CcSEcCtD
Ceftriaxone—Hypersensitivity—Temozolomide—malignant glioma	0.00277	0.00602	CcSEcCtD
Ceftriaxone—Diarrhoea—Carmustine—malignant glioma	0.00266	0.00578	CcSEcCtD
Ceftriaxone—Pruritus—Temozolomide—malignant glioma	0.00266	0.00578	CcSEcCtD
Ceftriaxone—Dizziness—Carmustine—malignant glioma	0.00257	0.00559	CcSEcCtD
Ceftriaxone—Diarrhoea—Temozolomide—malignant glioma	0.00257	0.00559	CcSEcCtD
Ceftriaxone—Dizziness—Temozolomide—malignant glioma	0.00249	0.0054	CcSEcCtD
Ceftriaxone—Vomiting—Carmustine—malignant glioma	0.00247	0.00537	CcSEcCtD
Ceftriaxone—Rash—Carmustine—malignant glioma	0.00245	0.00533	CcSEcCtD
Ceftriaxone—Dermatitis—Carmustine—malignant glioma	0.00245	0.00532	CcSEcCtD
Ceftriaxone—Headache—Carmustine—malignant glioma	0.00244	0.00529	CcSEcCtD
Ceftriaxone—Vomiting—Temozolomide—malignant glioma	0.00239	0.00519	CcSEcCtD
Ceftriaxone—Rash—Temozolomide—malignant glioma	0.00237	0.00515	CcSEcCtD
Ceftriaxone—Dermatitis—Temozolomide—malignant glioma	0.00237	0.00514	CcSEcCtD
Ceftriaxone—Headache—Temozolomide—malignant glioma	0.00236	0.00512	CcSEcCtD
Ceftriaxone—Nausea—Carmustine—malignant glioma	0.00231	0.00502	CcSEcCtD
Ceftriaxone—Nausea—Temozolomide—malignant glioma	0.00223	0.00485	CcSEcCtD
